The company today announced the opening of its second space in biotech hub Basel, Switzerland.
The 4,770 square metre space will offer ready-to-use laboratory spaces, along with essential operational support services.
Our holistic solution frees scientists from operations headaches, so they can save time and focus on science.
We service, you discover, is our mantra.
In good biotech company
40% off TNW Conference!
One of the first tenants of Superlab Suisses Basel facilities is Skyhawk Therapeutics.
The drug discovery specialist recently announced a partnership inRNA research targeting rare neurological diseases with global biopharmaceutical company Ipsen.
The Basel space is Superlab Suisses second offering.
The first is in Lausanne, and a third will open in Zurich in early 2025.
Tenants at one facility will also have access to the others.
The company also has plans for further expansion in Europe, as well as the US and Asia.
Story byLinnea Ahlgren
Linnea is the senior editor at TNW, having joined in April 2023.
Dabbles in gaming and fitness wearables.
But first, coffee.
